{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:41:43Z","timestamp":1761543703997,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006225","name":"Oak Ridge Associated Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006225","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cgh.2020.08.042","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T02:17:32Z","timestamp":1597976252000},"page":"1670-1678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["No Association Between DAA Treatment for HCV Infection and Herpes Zoster Infection in Analysis of Data From 37 Clinical Trials"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3731-3372","authenticated-orcid":false,"given":"Maximilian D.","family":"Rohde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LaRee","family":"Tracy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi E.","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer S.","family":"El-Kamary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"Global Hepatitis Report 2017","key":"10.1016\/j.cgh.2020.08.042_bib1"},{"key":"10.1016\/j.cgh.2020.08.042_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2040622314551934","article-title":"Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C","volume":"6","author":"Cortez","year":"2015","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.cgh.2020.08.042_bib3","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7326\/M16-2575","article-title":"Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review","volume":"166","author":"Falade-Nwulia","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2020.08.042_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.4765","article-title":"Assessing the safety of direct-acting antiviral agents for hepatitis C","volume":"2","author":"McGlynn","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cgh.2020.08.042_bib5","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.cgh.2016.05.016","article-title":"Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents","volume":"14","author":"Perell\u00f3","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.08.042_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cgh.2016.12.010","article-title":"Direct-acting antiviral-induced Hepatitis C virus clearance and herpesvirus reactivation: a double face of Janus?","volume":"15","author":"Bruno","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.08.042_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cgh.2017.01.021","volume":"15","author":"Fernandez Carrillo","year":"2017","journal-title":"Reply. Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2020.08.042_bib8","first-page":"67","article-title":"Dual herpes virus reactivation complicated with encephalitis caused by direct-acting antiviral agents","volume":"24","author":"Chen","year":"2019","journal-title":"Neurology Asia"},{"key":"10.1016\/j.cgh.2020.08.042_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajg.2017.02.003","article-title":"Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case series","volume":"18","author":"El Kassas","year":"2017","journal-title":"Arab J Gastroenterol"},{"key":"10.1016\/j.cgh.2020.08.042_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2147\/IDR.S184598","article-title":"Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents","volume":"12","author":"Ghweil","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.cgh.2020.08.042_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3851\/IMP3072","article-title":"Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV HCV-coinfected subjects: a new immune restoration disease?","volume":"21","author":"Marocco","year":"2016","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cgh.2020.08.042_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.dld.2017.01.163","article-title":"Herpes virus reactivation during and after direct-acting antiviral therapy for hepatitis C virus infection","volume":"49","author":"Yokoo","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2020.08.042_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12879-015-1262-8","article-title":"Annual incidence rates of herpes zoster among an immunocompetent population in the United States","volume":"15","author":"Johnson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cgh.2020.08.042_bib14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N\u00a0Engl J Med"},{"year":"1979","author":"Rothman","series-title":"Epidemiologic analysis with a programmable calculator. No. 79-1649","key":"10.1016\/j.cgh.2020.08.042_bib15"},{"key":"10.1016\/j.cgh.2020.08.042_bib16","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.cgh.2020.08.042_bib17","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","article-title":"Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome","volume":"124","author":"Meissner","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cgh.2020.08.042_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","article-title":"Restoration of HCV-specific CD8+ T cell function by interferon-free therapy","volume":"61","author":"Martin","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2020.08.042_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2018.06.013","article-title":"Interleukin\u20136 and type 1 interferons inhibit varicella zoster virus replication in human neurons","volume":"522","author":"Como","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.cgh.2020.08.042_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13578-016-0086-6","article-title":"Type I interferon inhibits varicella-zoster virus replication by interfering with the dynamic interaction between mediator and IE62 within replication compartments","volume":"6","author":"Ku","year":"2016","journal-title":"Cell Biosci"},{"year":"2018","key":"10.1016\/j.cgh.2020.08.042_bib21"},{"key":"10.1016\/j.cgh.2020.08.042_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/liv.14011","article-title":"Hepatitis C: Is eradication possible?","volume":"39","author":"Lombardi","year":"2019","journal-title":"Liver Int"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520311514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356520311514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:35:09Z","timestamp":1761543309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356520311514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1542356520311514"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2020.08.042","relation":{},"ISSN":["1542-3565"],"issn-type":[{"type":"print","value":"1542-3565"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"No Association Between DAA Treatment for HCV Infection and Herpes Zoster Infection in Analysis of Data From 37 Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2020.08.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}